TXN · DEEP VALUE BRIEFING

Texas Instruments Incorporated (TXN)

published May 10, 2026 · price now $294.57 · market cap $269B

WATCH · medium confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Briefing

Texas Instruments is a Buffett-like business at a non-Buffett price. The moat looks real: sticky analog/embedded products, strong returns, durable end markets, and solid profitability. But at about 49x earnings and roughly 1% FCF yield, the stock offers little margin of safety. The core risk is not business collapse; it is overpaying for quality during a cyclical recovery narrative. For a long-term value investor, the right move is patience, not urgency.

Final stance: WATCH


Risk Commentary for the Long-Term Investor

1) Final Verdict

TXN appears low risk as a business, but elevated risk as a stock purchase today. Under Buffett’s framework, that distinction is critical. This is not about volatility or whether the chart keeps working. It is about whether buying now creates acceptable odds of good long-term returns without relying on optimistic assumptions.

Today, the answer is not yet.


2) Strongest Arguments from Each Analyst

Fundamentals Analyst — strongest point

TXN’s economics are clearly high quality:

  • Gross margin: 57.0%
  • ROE: 30.7%
  • ROIC: 19.5%
  • ROA: 14.5%

These are the marks of a durable, efficient franchise, not a weak cyclical operator.

Value Analyst — strongest point

The valuation case is the biggest warning:

  • Current price: $288
  • Buffett avg value: $50.99
  • FCF avg value: $38.24
  • Damodaran avg value: $71.74

Even allowing for model conservatism, the gap is too large to ignore. The market is pricing in a lot of success already.

Growth Analyst — strongest point

Growth is improving, but not in a way that fully validates the premium:

  • Revenue growth YoY: 13.0%
  • Net income growth YoY: 4.2%
  • FCF growth YoY: 73.8%

That mix says recovery/inflection, not obvious broad-based earnings acceleration. Good business, but not a classic fast grower.

Risky Analyst — strongest point

The best bullish argument is that trailing earnings may understate normalized earnings power during a cyclical recovery, especially with internal manufacturing leverage. That is valid and should not be dismissed.

Safe Analyst — strongest point

The best conservative point is the most important one: a wonderful business can still be a poor investment if bought at too high a price. At this valuation, modest disappointment could produce mediocre returns even if the business stays strong.

Neutral Analyst — strongest point

The most balanced insight: TXN likely deserves a premium multiple versus many semiconductor peers, but not a blank check. A watchful, conditional approach fits best.


3) Rationale Anchored in the Debate

A. Business risk looks manageable

By Buffett standards, TXN has many favorable traits:

  • understandable business model
  • sticky customer relationships
  • long product life cycles
  • broad analog/embedded catalog
  • likely durable relevance in industrial and automotive electronics
  • strong profitability and returns on capital

That makes TXN less risky than many semiconductor firms, despite being in a cyclical industry.

B. Stock risk is the real issue

The bear case wins because valuation overwhelms quality at the current quote.

At:

  • ~49x earnings
  • ~1% FCF yield
  • valuation far above multiple intrinsic-value frameworks

you are no longer buying resilience cheaply. You are paying a premium for resilience, recovery, and continued market enthusiasm.

That violates the core value principle of margin of safety.

C. Recovery is visible, but not fully proven

The bullish side argues that revenue and FCF are inflecting before earnings. That may be true. But the present evidence is mixed:

  • revenue up 13%
  • net income up only 4.2%

That gap matters. It suggests the recovery story is plausible, but not yet fully confirmed in bottom-line earning power. For a value investor, that means the market may be capitalizing the future too aggressively.

D. Internal manufacturing is both strength and risk

The bulls are right that manufacturing scale and 300mm analog capacity can be a moat. But the bears are right that this also creates fixed-cost leverage:

  • if utilization rises, margins can improve nicely
  • if utilization disappoints, earnings pressure can persist

So this is not a “risk-free quality premium” situation.

E. Sentiment is favorable, which reduces opportunity

Recent momentum/news language suggests the market is already rewarding TXN for improving visibility. That is not automatically bearish, but from a Buffett lens it usually means opportunity is shrinking, not expanding. Value investors do best when sentiment is skeptical, not comfortable.


4) Refined Investor Plan

Starting from your original plan: WATCH

I would refine it to:

WATCH — high-quality business, wait for either better price or better proof

What to do now

  • Do not initiate a full position here
  • Keep TXN high on the watchlist
  • If portfolio construction requires semiconductor exposure, at most consider a small starter position, not a full commitment

What would improve the case

Add only if one or both occur:

  1. Valuation improves materially
  • a meaningful pullback
  • or earnings catch up enough to reduce the effective multiple
  1. Operational proof strengthens
  • net income growth begins to better match revenue growth
  • free cash flow remains strong after capex
  • gross margins/utilization confirm manufacturing advantage
  • industrial and automotive demand appears durable, not merely inventory normalization

What would weaken the case

  • revenue keeps growing but earnings conversion stays weak
  • utilization disappoints
  • FCF rebound fades after the bounce
  • management repurchases heavily at elevated valuations
  • broader semiconductor enthusiasm cools and TXN remains expensive anyway

5) Lessons from Past Mistakes

The key prior mistake to avoid is a classic one: falling in love with a great business and rationalizing away valuation. That often produces disappointing returns without any obvious business failure.

Another common mistake is the mirror image: assuming every expensive quality name must be avoided forever. The better lesson is to separate:

  • business admiration

from

  • entry discipline

For TXN today, the right correction is not blind optimism or permanent rejection. It is disciplined patience.


Bottom Line

Texas Instruments fits the profile of a business a Buffett-style investor would admire. But admiration is not a substitute for a margin of safety. The company looks strong; the stock looks rich. That makes this a watchlist compounder, not an active value buy at current levels.

STANCE: WATCH

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 4, 2026; the market price was $294.57. Values are estimates, not predictions.

Owner earnings (Buffett)

Discounts owner earnings: the cash the business generates for its owners after the spending needed to keep it running.

Value per share: $31.27 / $44.67 / $107.81 (conservative / base / optimistic)

Starting Owner Earnings$2.9B
Growth: conservative / base / optimistic (2015–2025)2.0% / 2.0% / 2.5%
Projection10 years
Discount rate8.6%
Terminal growth2.5%
Shares outstanding920M
The history the growth rates come from (15 years)
2011$2.8B
2012$2.5B
2013$3.3B
2014$4.2B
2015$4.3B
2016$4.6B
2017$5.4B
2018$5.6B
2019$5.0B
2020$5.4B
2021$6.2B
2022$7.0B
2023$2.5B
2024$1.0B
2025$2.6B

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $72.48 / $92.40 / $162.79 (conservative / base / optimistic)

Starting Free Cash Flow$4.9B
Growth: conservative / base / optimistic (2020–2025)-4.5% / 1.1% / 15.2%
Projection10 years
Discount rate9.4%
Terminal growth4.5%
Shares outstanding920M
The history the growth rates come from (15 years)
2011$2.2B
2012$2.7B
2013$2.7B
2014$3.4B
2015$3.6B
2016$3.8B
2017$4.4B
2018$5.8B
2019$5.6B
2020$5.3B
2021$6.1B
2022$5.6B
2023$987M
2024$1.1B
2025$2.2B

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $41.08 / $76.49 / $124.18 (conservative / base / optimistic)

Starting Damodaran FCFF$5.2B
Growth: conservative / base / optimistic (2011–2025)-6.2% / 1.8% / 8.6%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt3.37%
Equity weight95%
WACC (discount rate)9.12%
Target operating margin (base)36.3%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding913M

This briefing is from May 10, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone app

The Monday letter

One email a week: what great value investors bought and sold, and what we make of it.

Send me the DeepValues Monday letter, one email a week. I can unsubscribe at any time. Information only, not investment advice. Privacy